GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Total Stockholders Equity

Biogena Group Invest AG (WBO:BIO) Total Stockholders Equity : €8.49 Mil (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Total Stockholders Equity?

Biogena Group Invest AG's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €8.49 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Biogena Group Invest AG's Book Value per Share for the quarter that ended in Jan. 2024 was €2.13. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Biogena Group Invest AG's Debt-to-Equity for the quarter that ended in Jan. 2024 was 0.00.


Biogena Group Invest AG Total Stockholders Equity Historical Data

The historical data trend for Biogena Group Invest AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Total Stockholders Equity Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Total Stockholders Equity
2.18 8.62 8.52 8.49

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Total Stockholders Equity 2.18 8.62 8.52 8.49

Biogena Group Invest AG  (WBO:BIO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Biogena Group Invest AG's Book Value per Share for the quarter that ended in Jan. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Biogena Group Invest AG's Debt-to-Equity for the quarter that ended in Jan. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.

Biogena Group Invest AG (WBO:BIO) Headlines